CasInvent Pharma
PrivateLast Round
Series A
Jul 2, 2025
Est. Valuation
$9M
Total Funding Raised
$7.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CasInvent Pharma is a biotechnology company that develops selective small molecule inhibitors of casein kinase 1 (CK1) for the treatment of resistant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CasInvent Pharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CasInvent Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 2, 2025 | ||||
| VC Round | Jul 2, 2025 | ||||
| Grant | Oct 1, 2024 | ||||
| Seed | May 28, 2024 | ||||
| Early Funding | Jan 30, 2024 | ||||
Seed | Sep 13, 2022 |
Key People
Founding team and executive leadership
CasInvent Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Garage Angels | Seed |
| i&i Prague | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 291% MoM, from 107 to 418.
CasInvent Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CasInvent Pharma's valuation, stock price, and market status.